Blog

Home/News/AstraZeneca contacted Gilead over potential megamerger: Bloomberg News

AstraZeneca contacted Gilead over potential megamerger: Bloomberg News

Britain’s AstraZeneca has approached U.S. rival Gilead Sciences about a possible merger to form one the world’s largest drug companies, Bloomberg News reported on Sunday, citing people familiar with the matter.

    

Written by

Peter Zirbes, ESQ. A Full Service Law Office 718 544 6300